Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
United Continental call volume above normal and directionally bullish » 13:05
05/20/22
05/20
13:05
05/20/22
13:05
UAL

United Airlines

$43.37 /

-0.82 (-1.86%)

Bullish option flow…

Bullish option flow detected in United Continental with 36,070 calls trading, 1.0x expected, and implied vol increasing almost 2 points to 60.23%. Jun-22 52.5 calls and 5/27 weekly 46 calls are the most active options, with total volume in those strikes near 8,800 contracts. The Put/Call Ratio is 0.44. Earnings are expected on July 20th.

ShowHide Related Items >><<
UAL United Airlines
$43.37 /

-0.82 (-1.86%)

UAL United Airlines
$43.37 /

-0.82 (-1.86%)

05/06/22 Wolfe Research
United Airlines upgraded to Peer Perform from Underperform at Wolfe Research
04/25/22 Citi
United Airlines price target raised to $71 from $58 at Citi
04/22/22 MKM Partners
United Airlines price target raised to $59 from $53 at MKM Partners
04/22/22 Morgan Stanley
United Airlines price target raised to $67 from $62 at Morgan Stanley
UAL United Airlines
$43.37 /

-0.82 (-1.86%)

UAL United Airlines
$43.37 /

-0.82 (-1.86%)

UAL United Airlines
$43.37 /

-0.82 (-1.86%)

UAL United Airlines
$43.37 /

-0.82 (-1.86%)

Options
American Airlines call volume above normal and directionally bullish » 12:45
05/20/22
05/20
12:45
05/20/22
12:45
AAL

American Airlines

$16.31 /

-0.44 (-2.63%)

Bullish option flow…

Bullish option flow detected in American Airlines with 54,523 calls trading, 1.0x expected, and implied vol increasing almost 2 points to 62.66%. Jun-22 18 calls and May-22 18 calls are the most active options, with total volume in those strikes near 14,700 contracts. The Put/Call Ratio is 0.61. Earnings are expected on July 21st.

ShowHide Related Items >><<
AAL American Airlines
$16.31 /

-0.44 (-2.63%)

AAL American Airlines
$16.31 /

-0.44 (-2.63%)

04/22/22 Argus
American Airlines upgraded to Buy from Hold at Argus
04/22/22 JPMorgan
American Airlines upgraded to Neutral with $26 target at JPMorgan
04/22/22 Deutsche Bank
American Airlines price target raised to $25 from $23 at Deutsche Bank
04/22/22 Barclays
American Airlines price target raised to $20 from $15 at Barclays
AAL American Airlines
$16.31 /

-0.44 (-2.63%)

AAL American Airlines
$16.31 /

-0.44 (-2.63%)

AAL American Airlines
$16.31 /

-0.44 (-2.63%)

AAL American Airlines
$16.31 /

-0.44 (-2.63%)

Options
Early notable gainers among liquid option names on May 20th » 09:55
05/20/22
05/20
09:55
05/20/22
09:55
MTCH

Match Group

$77.57 /

+2.53 (+3.37%)

, FTNT

Fortinet

$285.73 /

+10.72 (+3.90%)

, VFC

VF Corp.

$46.63 /

+2 (+4.48%)

, NOW

ServiceNow

$437.11 /

+10.06 (+2.36%)

, PFE

Pfizer

$51.85 /

+1.195 (+2.36%)

Notable gainers among…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VFC VF Corp.
$46.63 /

+2 (+4.48%)

PFE Pfizer
$51.85 /

+1.195 (+2.36%)

NOW ServiceNow
$437.11 /

+10.06 (+2.36%)

MTCH Match Group
$77.57 /

+2.53 (+3.37%)

FTNT Fortinet
$285.73 /

+10.72 (+3.90%)

MTCH Match Group
$77.57 /

+2.53 (+3.37%)

05/10/22 Piper Sandler
Match Group suit against Google not surprising, says Piper Sandler
05/09/22 Wells Fargo
Wells Fargo upgrades Match Group to Overweight, lowers price target to $115
05/09/22 Wells Fargo
Match Group upgraded to Overweight from Equal Weight at Wells Fargo
05/05/22 RBC Capital
Match Group price target lowered to $115 from $150 at RBC Capital
FTNT Fortinet
$285.73 /

+10.72 (+3.90%)

05/12/22 BMO Capital
Fortinet price target lowered to $325 from $360 at BMO Capital
05/11/22 Daiwa
Fortinet upgraded to Buy from Outperform at Daiwa
05/11/22 Deutsche Bank
Fortinet price target lowered to $300 from $320 at Deutsche Bank
05/11/22 KeyBanc
Fortinet price target lowered to $353 from $410 at KeyBanc
VFC VF Corp.
$46.63 /

+2 (+4.48%)

08:25 Today Wedbush
VF Corp. price target lowered to $50 from $61 at Wedbush
07:38 Today Credit Suisse
VF Corp. price target lowered to $61 from $81 at Credit Suisse
07:15 Today Stifel
VF Corp. price target lowered to $42 from $74 at Stifel
07:00 Today Baird
VF Corp. price target lowered to $60 from $80 at Baird
NOW ServiceNow
$437.11 /

+10.06 (+2.36%)

05/18/22 Wells Fargo
ServiceNow initiated with an Overweight at Wells Fargo
05/10/22 Truist
ServiceNow price target lowered to $600 from $700 at Truist
04/28/22 BMO Capital
ServiceNow price target raised to $595 from $570 at BMO Capital
04/28/22 Morgan Stanley
ServiceNow price target lowered to $745 from $810 at Morgan Stanley
PFE Pfizer
$51.85 /

+1.195 (+2.36%)

05/11/22 H.C. Wainwright
Biohaven Pharmaceutical downgraded to Neutral from Buy at H.C. Wainwright
05/11/22 Wedbush
Global Blood Therapeutics added to Best Ideas List at Wedbush
05/05/22 Stifel
Stifel keeps Buy rating on Arvinas, lowers price target to $82
05/04/22 Wells Fargo
Pfizer price target lowered to $55 from $60 at Wells Fargo
VFC VF Corp.
$46.63 /

+2 (+4.48%)

PFE Pfizer
$51.85 /

+1.195 (+2.36%)

NOW ServiceNow
$437.11 /

+10.06 (+2.36%)

MTCH Match Group
$77.57 /

+2.53 (+3.37%)

FTNT Fortinet
$285.73 /

+10.72 (+3.90%)

PFE Pfizer
$51.85 /

+1.195 (+2.36%)

FTNT Fortinet
$285.73 /

+10.72 (+3.90%)

VFC VF Corp.
$46.63 /

+2 (+4.48%)

PFE Pfizer
$51.85 /

+1.195 (+2.36%)

NOW ServiceNow
$437.11 /

+10.06 (+2.36%)

MTCH Match Group
$77.57 /

+2.53 (+3.37%)

FTNT Fortinet
$285.73 /

+10.72 (+3.90%)

VFC VF Corp.
$46.63 /

+2 (+4.48%)

PFE Pfizer
$51.85 /

+1.195 (+2.36%)

NOW ServiceNow
$437.11 /

+10.06 (+2.36%)

MTCH Match Group
$77.57 /

+2.53 (+3.37%)

FTNT Fortinet
$285.73 /

+10.72 (+3.90%)

Yesterday
Periodicals
CDC panel backs booster dose for Pfizer COVID vaccine for kids aged 5-11 » 15:56
05/19/22
05/19
15:56
05/19/22
15:56
PFE

Pfizer

$50.41 /

+ (+0.00%)

, BNTX

BioNTech

$165.98 /

+8.82 (+5.61%)

A CDC advisory panel has…

A CDC advisory panel has voted 11-1, with one abstention, to back a booster dose of the Pfizer (PFE) and BioNTech (BNTX) COVID vaccine for children aged five to eleven years old, according to multiple media reports.

ShowHide Related Items >><<
PFE Pfizer
$50.41 /

+ (+0.00%)

BNTX BioNTech
$165.98 /

+8.82 (+5.61%)

PFE Pfizer
$50.41 /

+ (+0.00%)

05/11/22 H.C. Wainwright
Biohaven Pharmaceutical downgraded to Neutral from Buy at H.C. Wainwright
05/11/22 Wedbush
Global Blood Therapeutics added to Best Ideas List at Wedbush
05/05/22 Stifel
Stifel keeps Buy rating on Arvinas, lowers price target to $82
05/04/22 Wells Fargo
Pfizer price target lowered to $55 from $60 at Wells Fargo
BNTX BioNTech
$165.98 /

+8.82 (+5.61%)

04/12/22 H.C. Wainwright
BioNTech price target lowered to $298 from $339 at H.C. Wainwright
04/11/22 H.C. Wainwright
H.C. Wainwright bullish on Matinas as LNC platform attracts BioNTech collab
04/05/22 Canaccord
BioNTech price target lowered to $300 from $450 at Canaccord
02/23/22 H.C. Wainwright
BioNTech price target lowered to $336 from $366 at H.C. Wainwright
PFE Pfizer
$50.41 /

+ (+0.00%)

BNTX BioNTech
$165.98 /

+8.82 (+5.61%)

PFE Pfizer
$50.41 /

+ (+0.00%)

BNTX BioNTech
$165.98 /

+8.82 (+5.61%)

PFE Pfizer
$50.41 /

+ (+0.00%)

BNTX BioNTech
$165.98 /

+8.82 (+5.61%)

PFE Pfizer
$50.41 /

+ (+0.00%)

BNTX BioNTech
$165.98 /

+8.82 (+5.61%)

Recommendations
GlaxoSmithKline price target raised to 1,750 GBp at Deutsche Bank » 15:00
05/19/22
05/19
15:00
05/19/22
15:00
GSK

GlaxoSmithKline

$43.62 /

+0.354625 (+0.82%)

Deutsche Bank analyst…

Deutsche Bank analyst Emmanuel Papadakis raised the firm's price target on GlaxoSmithKline to 1,750 GBp from 1,600 GBp and keeps a Hold rating on the shares.

ShowHide Related Items >><<
GSK GlaxoSmithKline
$43.62 /

+0.354625 (+0.82%)

GSK GlaxoSmithKline
$43.62 /

+0.354625 (+0.82%)

05/17/22 Roth Capital
Ideaya Biosciences price target raised to $46 from $42 at Roth Capital
05/13/22 Jefferies
Roche downgraded to Hold from Buy at Jefferies
04/29/22 Barclays
GlaxoSmithKline price target raised to 1,800 GBp from 1,775 GBp at Barclays
04/28/22 JPMorgan
GlaxoSmithKline price target raised to 1,900 GBp from 1,740 GBp at JPMorgan
GSK GlaxoSmithKline
$43.62 /

+0.354625 (+0.82%)

GSK GlaxoSmithKline
$43.62 /

+0.354625 (+0.82%)

GSK GlaxoSmithKline
$43.62 /

+0.354625 (+0.82%)

GSK GlaxoSmithKline
$43.62 /

+0.354625 (+0.82%)

Hot Stocks
Take-Two, Zynga stockholders approve proposals related to pending transaction » 11:20
05/19/22
05/19
11:20
05/19/22
11:20
TTWO

Take-Two

$124.77 /

+1.69 (+1.37%)

, ZNGA

Zynga

$8.55 /

+0.075 (+0.89%)

Take-Two Interactive…

Take-Two Interactive Software (TTWO) and Zynga (ZNGA) announced that the stockholders of each organization have approved all proposals related to Take-Two's combination with Zynga at each company's respective Special Meeting of Stockholders. As a result, the closing of the business combination is expected to occur on May 23, 2022 before market open, subject to the satisfaction of the remaining customary closing conditions. Shares of Zynga will cease trading after the market close on May 20, 2022, and following the closing, Zynga will no longer be listed on the NASDAQ exchange. Under the terms of the merger agreement, upon the closing of the transaction, Zynga will be combined with Take-Two on the terms set forth in the merger agreement and Zynga stockholders will be entitled to receive $3.50 in cash and 0.0406 shares of Take-Two common stock per share of Zynga common stock.

ShowHide Related Items >><<
ZNGA Zynga
$8.55 /

+0.075 (+0.89%)

TTWO Take-Two
$124.77 /

+1.69 (+1.37%)

TTWO Take-Two
$124.77 /

+1.69 (+1.37%)

05/17/22 Oppenheimer
Take-Two price target lowered to $190 from $215 at Oppenheimer
05/17/22 Jefferies
Take-Two guidance 'better than feared,' says Jefferies
05/17/22 Wedbush
Take-Two price target lowered to $145 from $180 at Wedbush
05/17/22 Morgan Stanley
Take-Two price target lowered to $195 from $215 at Morgan Stanley
ZNGA Zynga
$8.55 /

+0.075 (+0.89%)

04/19/22 Goldman Sachs
Zynga assumed with Not Rated at Goldman Sachs
ZNGA Zynga
$8.55 /

+0.075 (+0.89%)

TTWO Take-Two
$124.77 /

+1.69 (+1.37%)

ZNGA Zynga
$8.55 /

+0.075 (+0.89%)

TTWO Take-Two
$124.77 /

+1.69 (+1.37%)

ZNGA Zynga
$8.55 /

+0.075 (+0.89%)

TTWO Take-Two
$124.77 /

+1.69 (+1.37%)

ZNGA Zynga
$8.55 /

+0.075 (+0.89%)

TTWO Take-Two
$124.77 /

+1.69 (+1.37%)

Options
Early notable gainers among liquid option names on May 19th » 09:55
05/19/22
05/19
09:55
05/19/22
09:55
SNPS

Synopsys

$297.81 /

+24.88 (+9.12%)

, LYV

Live Nation

$91.09 /

+5.59 (+6.54%)

, MRNA

Moderna

$144.47 /

+6.725 (+4.88%)

, EXPE

Expedia

$123.33 /

+3.21 (+2.67%)

, FCX

Freeport McMoRan

$36.95 /

+1.605 (+4.54%)

Notable gainers among…

Notable gainers among liquid option names this morning include Synopsys (SNPS) $292.33 +19.76, Live Nation (LYV) $90.59 +5.20, Moderna (MRNA) $143.87 +6.16, Expedia (EXPE) $124.71 +4.56, and Freeport McMoRan (FCX) $36.45 +1.11.

ShowHide Related Items >><<
SNPS Synopsys
$297.81 /

+24.88 (+9.12%)

MRNA Moderna
$144.47 /

+6.725 (+4.88%)

LYV Live Nation
$91.09 /

+5.59 (+6.54%)

FCX Freeport McMoRan
$36.95 /

+1.605 (+4.54%)

EXPE Expedia
$123.33 /

+3.21 (+2.67%)

SNPS Synopsys
$297.81 /

+24.88 (+9.12%)

05/19/22 Needham
Synopsys price target raised to $380 from $370 at Needham
05/19/22 Wells Fargo
Synopsys price target lowered to $375 from $415 at Wells Fargo
04/13/22 Baird
Baird doesn't see 'much new' in Bloomberg report on Synopsys
01/10/22 KeyBanc
Synopsys price target raised to $445 from $395 at KeyBanc
LYV Live Nation
$91.09 /

+5.59 (+6.54%)

04/25/22 Rosenblatt
Live Nation initiated with a Buy at Rosenblatt
04/25/22 Benchmark
Live Nation initiated with a Buy at Benchmark
11/05/21 Jefferies
Live Nation price target raised to $125 from $103 at Jefferies
11/02/21 Cowen
Live Nation price target raised to $120 from $100 at Cowen
MRNA Moderna
$144.47 /

+6.725 (+4.88%)

05/17/22 Piper Sandler
Moderna price target lowered to $214 from $348 at Piper Sandler
04/20/22 Piper Sandler
Piper says 'do not be fooled,' Arcturus Phase 3 shows strong vaccine efficacy
04/19/22 Piper Sandler
Moderna's bivalent booster improves titers against omicron, says Piper Sandler
04/11/22 Piper Sandler
CFO leaves Dentsply for Moderna, outside replacement more likely, says Piper
EXPE Expedia
$123.33 /

+3.21 (+2.67%)

05/18/22 Redburn
Expedia upgraded to Buy from Neutral at Redburn
05/11/22 Piper Sandler
Expedia pullback a buying opportunity, says Piper Sandler
05/03/22 DA Davidson
Expedia price target raised to $195 from $167 at DA Davidson
05/03/22 Benchmark
Expedia price target raised to $275 from $265 at Benchmark
FCX Freeport McMoRan
$36.95 /

+1.605 (+4.54%)

04/22/22 BMO Capital
Freeport McMoRan price target lowered to $56 from $62 at BMO Capital
04/22/22 Deutsche Bank
Freeport McMoRan price target lowered to $47 from $50 at Deutsche Bank
04/21/22 Barclays
Freeport McMoRan price target raised to $29 from $28 at Barclays
04/05/22 Exane BNP Paribas
Freeport McMoRan downgraded to Neutral from Outperform at Exane BNP Paribas
SNPS Synopsys
$297.81 /

+24.88 (+9.12%)

MRNA Moderna
$144.47 /

+6.725 (+4.88%)

LYV Live Nation
$91.09 /

+5.59 (+6.54%)

FCX Freeport McMoRan
$36.95 /

+1.605 (+4.54%)

EXPE Expedia
$123.33 /

+3.21 (+2.67%)

  • 10
    Nov
  • 15
    Sep
SNPS Synopsys
$297.81 /

+24.88 (+9.12%)

MRNA Moderna
$144.47 /

+6.725 (+4.88%)

LYV Live Nation
$91.09 /

+5.59 (+6.54%)

FCX Freeport McMoRan
$36.95 /

+1.605 (+4.54%)

EXPE Expedia
$123.33 /

+3.21 (+2.67%)

SNPS Synopsys
$297.81 /

+24.88 (+9.12%)

MRNA Moderna
$144.47 /

+6.725 (+4.88%)

LYV Live Nation
$91.09 /

+5.59 (+6.54%)

FCX Freeport McMoRan
$36.95 /

+1.605 (+4.54%)

EXPE Expedia
$123.33 /

+3.21 (+2.67%)

SNPS Synopsys
$297.81 /

+24.88 (+9.12%)

MRNA Moderna
$144.47 /

+6.725 (+4.88%)

LYV Live Nation
$91.09 /

+5.59 (+6.54%)

FCX Freeport McMoRan
$36.95 /

+1.605 (+4.54%)

EXPE Expedia
$123.33 /

+3.21 (+2.67%)

Hot Stocks
Uber, Grocery Outlet partner for on-demand grocery delivery across west coast » 09:02
05/19/22
05/19
09:02
05/19/22
09:02
UBER

Uber

$22.46 /

-1.74 (-7.19%)

, GO

Grocery Outlet

$34.98 /

-1.78 (-4.84%)

Uber Technologies (UBER)…

Uber Technologies (UBER) and Grocery Outlet (GO) announced they are teaming up to pilot on-demand and scheduled grocery delivery. Starting today, 72 Grocery Outlet stores across California, Oregon, and Washington are available to shop through Uber and Uber Eats. "We are excited about the long-term potential of our eCommerce initiative at Grocery Outlet and this new partnership with Uber," said RJ Sheedy, President of Grocery Outlet. "We think it's important to make our great-value products available across another platform and to a greater audience, introducing Grocery Outlet to customers who may not have shopped with us before."

ShowHide Related Items >><<
UBER Uber
$22.46 /

-1.74 (-7.19%)

GO Grocery Outlet
$34.98 /

-1.78 (-4.84%)

UBER Uber
$22.46 /

-1.74 (-7.19%)

05/05/22 Oppenheimer
Uber price target lowered to $40 from $45 at Oppenheimer
05/05/22 MKM Partners
Uber price target lowered to $41 from $65 at MKM Partners
05/05/22 Needham
Uber price target lowered to $50 from $68 at Needham
05/05/22 Wedbush
Uber price target lowered to $38 from $48 at Wedbush
GO Grocery Outlet
$34.98 /

-1.78 (-4.84%)

05/11/22 R5 Capital
Grocery Outlet upgraded to Hold from Sell at R5 Capital
05/11/22 Craig-Hallum
Craig-Hallum upgrades Grocery Outlet to Buy, raises price target to $43
05/11/22 Craig-Hallum
Grocery Outlet upgraded to Buy from Hold at Craig-Hallum
05/11/22 Deutsche Bank
Grocery Outlet upgraded to Buy from Hold at Deutsche Bank
UBER Uber
$22.46 /

-1.74 (-7.19%)

GO Grocery Outlet
$34.98 /

-1.78 (-4.84%)

  • 29
    Jul
UBER Uber
$22.46 /

-1.74 (-7.19%)

UBER Uber
$22.46 /

-1.74 (-7.19%)

GO Grocery Outlet
$34.98 /

-1.78 (-4.84%)

UBER Uber
$22.46 /

-1.74 (-7.19%)

Hot Stocks
Spirit Airlines urges stockholders to reject JetBlue tender offer » 06:52
05/19/22
05/19
06:52
05/19/22
06:52
SAVE

Spirit Airlines

$19.41 /

-1.23 (-5.96%)

, JBLU

JetBlue

$9.92 /

-0.295 (-2.89%)

, AAL

American Airlines

$16.91 /

-0.915 (-5.13%)

, ULCC

Frontier Group

$9.44 /

-0.27 (-2.78%)

Spirit Airlines (SAVE)…

Spirit Airlines (SAVE) announced that its board of directors, after consultation with its outside financial and legal advisors, has unanimously determined that the unsolicited tender offer from JetBlue (JBLU) to acquire all outstanding shares of Spirit's common stock for $30 per share in cash is not in the best interests of Spirit and its stockholders. In its analysis, the board determined that the JetBlue transaction faces substantial regulatory hurdles, especially while the Northeast Alliance, or NEA, with American Airlines (AAL) remains in effect, and is, as a result, not reasonably capable of being consummated and is not superior to Spirit's agreed merger transaction with Frontier (ULCC). Accordingly, the Spirit Board unanimously recommends that Spirit stockholders not tender any of their shares into the offer and continues to recommend that stockholders vote for the merger agreement with Frontier. "JetBlue's tender offer has not addressed the core issue of the significant completion risk and insufficient protections for Spirit stockholders," said Mac Gardner, chairman of the board of directors for Spirit Airlines. "Based on our own research and the advice of antitrust and economic experts, our view is that the proposed combination of JetBlue and Spirit lacks any realistic likelihood of obtaining regulatory approval, while our company faces a long and bleak limbo period as we await resolution. In that scenario, a $1.83 per share reverse break-up fee will not come close to adequately compensating Spirit stockholders for the significant business disruption Spirit will face during what JetBlue acknowledges will be a protracted regulatory process. Our pending merger with Frontier is advancing as planned, and we continue to recommend that Spirit stockholders vote for the merger with Frontier on June 10th, as we believe the combination of these two ULCCs is the best way to deliver maximum value to Spirit stockholders."

ShowHide Related Items >><<
ULCC Frontier Group
$9.44 /

-0.27 (-2.78%)

SAVE Spirit Airlines
$19.41 /

-1.23 (-5.96%)

JBLU JetBlue
$9.92 /

-0.295 (-2.89%)

AAL American Airlines
$16.91 /

-0.915 (-5.13%)

SAVE Spirit Airlines
$19.41 /

-1.23 (-5.96%)

05/05/22 Deutsche Bank
Spirit Airlines price target lowered to $27 from $38 at Deutsche Bank
04/11/22 MKM Partners
JetBlue upgraded to Neutral at MKM Partners on valuation
04/06/22 MKM Partners
MKM Partners expects to see 'heavy regulatory pushback' to JetBlue-Spirit deal
04/06/22 Evercore ISI
Spirit Airlines downgraded to In Line at Evercore after JetBlue's 'plan B' bid
JBLU JetBlue
$9.92 /

-0.295 (-2.89%)

04/26/22 JPMorgan
JetBlue double downgraded to Underweight from Overweight at JPMorgan
04/22/22 Deutsche Bank
JetBlue downgraded to Hold on headwinds at Deutsche Bank
04/22/22 Deutsche Bank
JetBlue downgraded to Hold from Buy at Deutsche Bank
04/12/22 Wolfe Research
JetBlue downgraded to Underperform from Peer Perform at Wolfe Research
AAL American Airlines
$16.91 /

-0.915 (-5.13%)

04/22/22 Argus
American Airlines upgraded to Buy from Hold at Argus
04/22/22 JPMorgan
American Airlines upgraded to Neutral with $26 target at JPMorgan
04/22/22 Deutsche Bank
American Airlines price target raised to $25 from $23 at Deutsche Bank
04/22/22 Barclays
American Airlines price target raised to $20 from $15 at Barclays
ULCC Frontier Group
$9.44 /

-0.27 (-2.78%)

02/15/22 Wolfe Research
Wolfe upgrades three, downgrades one in U.S. Airlines as new analyst takes over
02/15/22 Wolfe Research
Frontier Group assumed at Outperform from Peer Perform at Wolfe Research
ULCC Frontier Group
$9.44 /

-0.27 (-2.78%)

SAVE Spirit Airlines
$19.41 /

-1.23 (-5.96%)

JBLU JetBlue
$9.92 /

-0.295 (-2.89%)

AAL American Airlines
$16.91 /

-0.915 (-5.13%)

ULCC Frontier Group
$9.44 /

-0.27 (-2.78%)

SAVE Spirit Airlines
$19.41 /

-1.23 (-5.96%)

JBLU JetBlue
$9.92 /

-0.295 (-2.89%)

AAL American Airlines
$16.91 /

-0.915 (-5.13%)

SAVE Spirit Airlines
$19.41 /

-1.23 (-5.96%)

AAL American Airlines
$16.91 /

-0.915 (-5.13%)

SAVE Spirit Airlines
$19.41 /

-1.23 (-5.96%)

JBLU JetBlue
$9.92 /

-0.295 (-2.89%)

AAL American Airlines
$16.91 /

-0.915 (-5.13%)

Conference/Events
Pfizer management to meet with Oppenheimer » 04:55
05/19/22
05/19
04:55
05/19/22
04:55
PFE

Pfizer

$50.41 /

-0.93 (-1.81%)

Meeting to be held in New…

Meeting to be held in New York on May 19 hosted by Oppenheimer.

ShowHide Related Items >><<
PFE Pfizer
$50.41 /

-0.93 (-1.81%)

PFE Pfizer
$50.41 /

-0.93 (-1.81%)

05/11/22 H.C. Wainwright
Biohaven Pharmaceutical downgraded to Neutral from Buy at H.C. Wainwright
05/11/22 Wedbush
Global Blood Therapeutics added to Best Ideas List at Wedbush
05/05/22 Stifel
Stifel keeps Buy rating on Arvinas, lowers price target to $82
05/04/22 Wells Fargo
Pfizer price target lowered to $55 from $60 at Wells Fargo
PFE Pfizer
$50.41 /

-0.93 (-1.81%)

PFE Pfizer
$50.41 /

-0.93 (-1.81%)

PFE Pfizer
$50.41 /

-0.93 (-1.81%)

PFE Pfizer
$50.41 /

-0.93 (-1.81%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.